Sports medicine

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

Retrieved on: 
Friday, March 8, 2024

JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.
  • Following our December 2023 financing, we expect to have sufficient cash to fund operations through the first half of 2025,” said Miranda Toledano, CEO of Entera.
  • Financial Results for the year Ended December 31, 2023
    As of December 31, 2023, Entera had cash and cash equivalents of $11.0 million.
  • Operating expenses for year ended December 31, 2023 were $8.9 million, as compared to $13.0 million for the year ended December 31, 2022.

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Retrieved on: 
Thursday, February 29, 2024

Gross profit for the quarter ended December 31, 2023 was $48.5 million, or 75% of net revenue, compared to $38.2 million, or 73% of net revenue, for the fourth quarter of 2022.

Key Points: 
  • Gross profit for the quarter ended December 31, 2023 was $48.5 million, or 75% of net revenue, compared to $38.2 million, or 73% of net revenue, for the fourth quarter of 2022.
  • Total operating expenses for the quarter ended December 31, 2023 were $35.8 million, compared to $32.2 million for the same period in 2022.
  • Non-GAAP adjusted EBITDA for the quarter ended December 31, 2023 was $22.3 million, or 34% of net revenue, compared to $14.9 million, or 28% of net revenue, for the fourth quarter of 2022.
  • Total net revenue for the year ended December 31, 2023 was $197.5 million, compared to $164.4 million in 2022.

Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement

Retrieved on: 
Wednesday, February 28, 2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR).

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR).
  • This marks the first time that the USAISR has entered into a master agreement of this nature with an industry-leading medical technology company.
  • The Master CRADA represents an enterprise-wide opportunity for Smith+Nephew across all business units - Advanced Wound Management, Orthopaedics and Sports Medicine - to enter into multiple collaborative research efforts.
  • “The pre-negotiated key terms and conditions of the Master CRADA provide the broad legal framework under which for multiple, future collaborative research efforts will be assigned.

Aspetar Attains ACGME International Accreditation

Retrieved on: 
Tuesday, February 27, 2024

Chicago, IL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ACGME International (ACGME-I) is proud to announce that Aspetar Orthopaedic and Sports Medicine Hospital in Doha, Qatar has been granted ACGME-I Initial Accreditation as a Sponsoring Institution.

Key Points: 
  • Chicago, IL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ACGME International (ACGME-I) is proud to announce that Aspetar Orthopaedic and Sports Medicine Hospital in Doha, Qatar has been granted ACGME-I Initial Accreditation as a Sponsoring Institution.
  • Aspetar is also one of 11 International Olympic Committee Research Centres.
  • “This accreditation underscores our dedication to equipping our staff with unparalleled education and expertise,” said Aspetar Chief Executive Officer Dr. Abdulaziz Al Kuwari.
  • ACGME International (ACGME-I) is an independent 501(c)(3) organization currently providing accreditation services to 200 graduate medical education programs in 23 institutions across 12 countries.

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Retrieved on: 
Tuesday, February 27, 2024

CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference at 11:10 a.m.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference at 11:10 a.m.
  • ET on Tuesday, March 5, 2024.
  • A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com .

Spinal Rehab & Sports Medicine Announces Dr. Bob Meyer's 25-Year Anniversary in Sports Medicine

Retrieved on: 
Wednesday, February 21, 2024

Spinal Rehab Sports Medicine utilizes the latest advancements in sports medicine to ensure optimal recovery outcomes.

Key Points: 
  • Spinal Rehab Sports Medicine utilizes the latest advancements in sports medicine to ensure optimal recovery outcomes.
  • "At Spinal Rehab & Sports Medicine, we take pride in offering unparalleled sports medicine services to the Austin community," said Dr. Bob.
  • Athletes in and around Austin, TX, looking for exceptional sports medicine care need look no further than Dr. Bob and Spinal Rehab & Sports Medicine.
  • For more information about Dr. Bob and Spinal Rehab & Sports Medicine, please visit https://spinalrehabsportsmedicine.com/ .

ChristianaCare Announces Partnership with Emerus Holdings Inc. to Build and Operate Three Neighborhood Hospitals in Southeastern Pennsylvania

Retrieved on: 
Tuesday, February 27, 2024

That’s the vision ChristianaCare and its partner, Emerus Holdings Inc., have for three neighborhood hospitals they will open in Pennsylvania in 2025.

Key Points: 
  • That’s the vision ChristianaCare and its partner, Emerus Holdings Inc., have for three neighborhood hospitals they will open in Pennsylvania in 2025.
  • Together, the three neighborhood hospitals represent a new layer of care coming to southeastern Pennsylvania.
  • ChristianaCare has partnered with Emerus Holdings Inc ., the nation’s leading developer of neighborhood hospitals (also referred to as micro-hospitals), to develop and operate the three neighborhood hospitals.
  • “We are proud to partner with ChristianaCare, one of the nation’s leading health care systems,” said Emerus CEO Vic Schmerbeck.

Nominations Now Open for Henry Schein Medical’s Athletics and Schools 2024 Rising Star Award

Retrieved on: 
Thursday, February 22, 2024

In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting nominations for its Henry Schein Medical Athletics and Schools 2024 Rising Star Award .

Key Points: 
  • In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting nominations for its Henry Schein Medical Athletics and Schools 2024 Rising Star Award .
  • Nominations for the 2024 Rising Star Award must be submitted here by March 3, 2024.
  • Once finalists are chosen, voting for the 2024 Rising Star Award winner will be open to the public here from March 23, 2024, through March 27, 2024.
  • For more information about Henry Schein Medical’s Athletics and Schools Rising Star Award, click here .

Lazurite® Adds Intuitive Modern Medical Solutions as New Distributor of the ArthroFree® System

Retrieved on: 
Monday, February 19, 2024

Medical device and technology company Lazurite® today announced that it has added Intuitive Modern Medical Solutions (IMMS) as a distributor of its ArthroFree® Wireless Camera System for the state of New York except New York City.

Key Points: 
  • Medical device and technology company Lazurite® today announced that it has added Intuitive Modern Medical Solutions (IMMS) as a distributor of its ArthroFree® Wireless Camera System for the state of New York except New York City.
  • View the full release here: https://www.businesswire.com/news/home/20240219963488/en/
    IMMS has an evaluation laboratory in its office where surgeons can try out the ArthroFree system.
  • (Photo: Business Wire)
    ArthroFree is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery.
  • “Lazurite is delighted to have IMMS join our growing distributor network and in-house sales team,” Lazurite President Leah Brownlee said.

Celebrate the Heroes of Sports Medicine: Nominate an Athletic Trainer for the 2024 Perry Weather AT Excellence Award!

Retrieved on: 
Wednesday, March 6, 2024

Perry Weather announces the second annual Perry Weather Athletic Trainer Excellence Award.

Key Points: 
  • Perry Weather announces the second annual Perry Weather Athletic Trainer Excellence Award.
  • /PRNewswire-PRWeb/ -- Perry Weather , a leading weather monitoring platform and advocate for athletic safety and well-being, is proud to announce the second annual Perry Weather Athletic Trainer Excellence Award.
  • "We are thrilled to recognize the champions of sports medicine who tirelessly work behind the scenes to ensure athlete well-being," says Colin Perry, CEO of Perry Weather.
  • The Perry Weather Athletic Trainer Excellence Award seeks to shine a light on these champions of sports medicine and celebrate their contributions.